STERIS (STE) agreed to buy Xodus Medical for $2.1B plus earnout. Strategic, financial and risk analysis for investors — dated 2026-10-13.
STERIS (STE) board cut to nine members after 2026 AGM elections. Investors should monitor governance, restructuring and legal risks tied to recent consolidation.
STERIS (STE) to close two plants and incur $55-$70M restructuring charges as part of a manufacturing consolidation and ongoing efficiency program.